glp-1 fda approved for weight loss New Pill Foundayo (Orforglipron) Gets Approval Obesity Is Semaglutide GLP-1 Safe for
Description
,
This combination of increased usage and expanded state coverage has increased Medicaid spending on GLP-1s for obesity to more than $500 million in October 2024 alone, with total expenditures reaching $3.5 billion over the past 12 months
This can create a more aged or gaunt look sometimes called Ozempic face. - not a nice phrase in my opinion
Clin Med (Lond) (2023) 23(4):33746
If youre reading this, chances are that you or someone close to you is struggling with this pesky side effect of Ozempic
Suran, Melissa
